International Consortium of Research Excellence of the Theodor-Billroth-Academy® (TBA ®)
International group with shared vision of improving patient and cancer care through long-term orientated projects (big data, clinical trials, translational research)
“Now the time, the main task is critique;
knowledge, experience and calm belongs to it”
~ Theodor Billroth (1829-1894
(2012) Tumor Response Criteria: are they appropriate? Invited Editorial by Future Oncology 8: 903-906.
(2012) Randomized Clinical Trials for Colorectal Cancer Peritoneal Surface Malignancy. Surg Clin N Am 21: 665-688.
(2013) Patients at risk for peritoneal surface malignancy of colorectal cancer origin: the role of 2nd look laparotomy. J Cancer 4: 262-269.
(2013) Multi-parametric MRI-directed focal salvage permament interstitital brachytherapy for locally recurrent adenocarcinoma of the prostate: a novel approach. J Cancer 4:262-269.
(2013) Significance of infectious agents in colorectal cancer development. J Cancer 4:227-240.
(2013) The diagnostic and prognostic role of microRNA in colorectal cancer – a comprehensive review. J Cancer 4:281-295.
(2013) Anorectal malignant melanoma: Extensive 45-year review and proposal for a novel staging classification. Journal of American College of Surgeons 217: 324-335.
(2013) Serum-Based DNA Methylation Biomarkers in Colorectal Cancer: Potential for Screening and Early Detection. J Cancer 4: 210-216.
(2013) Evidence-based Guidelines for Precision Risk Stratification-Based Screening (PRSBS) for Colorectal Cancer: Lessons learned from the US Armed Forces: Consensus and Future Directions. J Cancer 4: 172-192.
(2013) Colorectal Stem Cells as Biomarkers: Where it all starts? Journal of Surgical Oncology 107: 791-793.
(2013) Tumor-infiltrating immune cells promoting tumor invasion and metastasis: existing theories. J Cancer4: 84-95.
(2014) Carcinomatosis: Cytoreduction and Heated Intraperitoneal Chemotherapy (HIPEC) Versus Palliation. In S.R.Steele et al. (eds.) Complexities in Colorectal Surgery. Springer Science + Business Media New York 2014.
(2014) Therapeutic approaches to gastroesophageal junction adenocarcinomas. Ann N Y Acad Sci 1325: 197–210.
(2014) Current Approaches, Challenges and Future Directions for Monitoring Treatment Response in Prostate Cancer. J Cancer 5(1): 3-24.
(2014) Current Approaches and Challenges For Monitoring Treatment Response in Colon and Rectal Cancer. J Cancer 5(1): 31-43.
(2014) Future Directions for Monitoring Treatment Response in Colorectal Cancer. J Cancer 5(1): 44-57.
(2014) Early Detection of colorectal cancer recurrence in patients undergoing surgery with curative intent: current status and challenges. J Cancer 5(4): 262-271.
(2014) Future Directions for the Early Detection of Colorectal Cancer Recurrence. J Cancer 5(4): 272-280.
(2014) Treatment of Acute Abdominal Pain in the Emergency Room: A Review of the Literature. Eur J Pain 18(7): 902-913.
(2014) Time-dependent Estimates of Recurrence and Survival in Colon Cancer: Clinical Decision Support System Tool Development for Adjuvant Therapy and Oncological Outcome Assessment. Am Surg 80(5): 441-453.
(2014) Are Criteria Measuring Response In Esophageal Cancer Appropriate? Ann N Y Acad Sci 1325: 197-210.
(2014) Imagine a World Without Cancer. BMC Cancer 14: 1-8.
(2014) Undervalued criteria in the evaluation of multimodal trials for upper GI cancers. Cancer Invest 32(10): 497-506.
(2014) Epistemology of the Origin of Cancer: A New Paradigm. BMC Cancer 14: 1-15.
(2014) Cell-Cell communication in tumor microenvironment, carcinogenesis and anticancer treatment. Cell Physiol Biochem 34: 213-243.
(2014) Zum Nutzen von Metformin in der Krebs-Therapie. CHAZ 15: 680-684.
(2016) Genomics, microRNA, epigenetics, and proteomics for future diagnosis, treatment and monitoring response n upper GI cancers. Clin Trans Med 5: 1-16.
(2016) Somatic Mutation Theory – Why it’s Wrong for Most Cancers. Cell Physiol Biochem 38: 1663-1680.
(2017) The New York Academy of Sciences Magazine, Fall 2017 - Imaging The Next 100 Years: Slow but steady: Closing In A World Without Cancer.
(2018) Science belongs to no one — and to everyone. 4open 1: 1-11.
Munich | Germany – Sacramento, California | USA